Prosus Invests $460 million in French health tech Alan (opens original article in a new tab)
Prosus invested $460 million in French health tech company Alan, raising its valuation to $6.3 billion and supporting global expansion and AI development.
- Prosus invested $460 million in French health tech company Alan
- Alan's valuation reached $6.3 billion following the investment
- Alan will use the funding for global expansion and AI product development
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.